Single Injection Technique Prolotherapy for Hypermobility Disorders of TMJ Using 25% Dextrose: A Clinical Study.

Abstract

Hypermobility disorders of the Temporomandibular joint (TMJ) can be treated by both conservative and surgical approaches. Conservative approaches should be considered as first line treatment for such disorders. Prolotherapy with 25% dextrose being injected into the posterior pericapsular tissues is one such treatment modality with favorable outcomes. To study the efficacy of single injection of 25% dextrose in pericapsular tissues in the management of hypermobility joint disorders of TMJ as first line treatment. We have studied a total of 23 patients suffering from either chronic recurrent dislocation or subluxation of the TMJ who were treated with the single injection technique prolotherapy with 25% dextrose into the pericapsular tissues along with auriculotemporal nerve block and found encouraging results. Overall success rate in our study was 91.3% (21/23) with a minimum follow up period of 13.9 months. Number of successfully treated patients requiring one injection was 7 (30.4%), two injections was 8 (34.7%) and requiring three injections was 6 (26.1%). There were no permanent complications. Hence the use of 25% dextrose as a proliferant to treat hypermobilty disorders of the TMJ is recommended by us as a first line treatment option as it is safe, economical and an easy procedure associated with minimal morbidity.